FY2026 Earnings Forecast for Neogen Issued By Zacks Research

Neogen Corporation (NASDAQ:NEOG) – Zacks Research decreased their FY2026 earnings estimates for Neogen in a report issued on Tuesday, August 19th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $0.30 for the year, down from their prior forecast of $0.38. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share. Zacks Research also issued estimates for Neogen’s Q4 2027 earnings at $0.09 EPS, FY2027 earnings at $0.36 EPS and FY2028 earnings at $0.35 EPS.

A number of other research analysts have also weighed in on NEOG. Guggenheim dropped their price target on shares of Neogen from $13.00 to $10.00 and set a “buy” rating on the stock in a research report on Monday, June 30th. William Blair lowered shares of Neogen from an “outperform” rating to a “market perform” rating in a research report on Tuesday, July 29th. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $7.50.

Neogen Stock Up 0.7%

NEOG opened at $5.64 on Friday. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.32 and a quick ratio of 2.22. The company’s 50-day moving average is $5.11 and its 200 day moving average is $6.61. Neogen has a fifty-two week low of $3.87 and a fifty-two week high of $17.95. The firm has a market capitalization of $1.23 billion, a P/E ratio of -1.12 and a beta of 1.79.

Institutional Trading of Neogen

Several hedge funds have recently added to or reduced their stakes in the stock. CHICAGO TRUST Co NA raised its position in shares of Neogen by 19.1% in the first quarter. CHICAGO TRUST Co NA now owns 12,498 shares of the company’s stock valued at $108,000 after purchasing an additional 2,000 shares during the period. Ascent Group LLC raised its position in shares of Neogen by 17.8% in the fourth quarter. Ascent Group LLC now owns 14,340 shares of the company’s stock valued at $174,000 after purchasing an additional 2,165 shares during the period. California State Teachers Retirement System raised its position in shares of Neogen by 1.1% in the second quarter. California State Teachers Retirement System now owns 191,084 shares of the company’s stock valued at $913,000 after purchasing an additional 2,166 shares during the period. Avanza Fonder AB raised its position in shares of Neogen by 17.9% in the second quarter. Avanza Fonder AB now owns 16,435 shares of the company’s stock valued at $79,000 after purchasing an additional 2,499 shares during the period. Finally, Yousif Capital Management LLC raised its position in shares of Neogen by 3.9% in the first quarter. Yousif Capital Management LLC now owns 74,508 shares of the company’s stock valued at $646,000 after purchasing an additional 2,769 shares during the period. Institutional investors own 96.73% of the company’s stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.